) reported that pretest injection of FG7142, a GABA inverse agonist, alleviated infantile amnesia in rats. From this, it was concluded that GABAergic neurotransmission is involved in the forgetting seen in the developing rat. The present study extends that finding by examining the role of GABA in the reactivation of a forgotten memory in the infant rat. Sixteen-day-old rats were conditioned to fear a white noise. When tested 3 days later, rats that had not received a reminder treatment exhibited substantial forgetting. Reactivation of memory (as assessed by high levels of freezing) was observed in rats that were given a reminder shock and injected with saline the day before test. However, rats given a reminder shock and injected with midazolam immediately afterward failed to exhibit the reactivation effect. A subsequent experiment replicated this finding and further showed that midazolam did not reduce the memory reactivation effect when injected 2 hr after the reminder episode. From this, it appears that alterations in GABAergic neurotransmission may be an underlying process mediating memory reactivation in the infant rat.
Forgetting, a reduction in performance after learning, can be caused by a variety of sources. For example, retrograde amnesia refers to the situation where a physiological insult (e.g., electric convulsive shock; hypothermia) following learning causes a performance decrement at a subsequent test. In proactive interference, previously acquired memories have a detrimental effect on the retention of the target information that was learned after those memories were encoded. Among the many sources of forgetting, perhaps the most familiar and fundamental would be spontaneous forgetting that is due to the simple passage of time. Not much is known about the neural processes of spontaneous forgetting, however. This is in part because Pavlovian fear conditioning is the most widely used learning paradigm in the neurobiological examination of memory. Typically, in Pavlovian fear conditioning, rats are given presentations of an initially neutral conditioned stimulus (CS; e.g., tone) paired with an aversive unconditioned stimulus (US; e.g., footshock); subsequent presentations of the CS elicit various conditioned fear responses (e.g., freezing). Memory formed as a result of Pavlovian conditioning is extremely well retained (e.g., spontaneous forgetting was not observed even after 16 months in the adult rat; Gale et al., 2004 ). Hence, not many studies have examined spontaneous forgetting in adult rats because it is rarely observed.
A potential solution to this problem is examining spontaneous forgetting in the developing rat. Infant rats typically display very rapid spontaneous forgetting compared with adult rats, a phenomenon commonly referred to as infantile amnesia (for a review, see Campbell & Spear, 1972) . In this sort of developmental study, there are typically no age differences in retention when testing occurs soon after training, indicating that rats of all ages are equally able to acquire, consolidate, and express fear. However, when testing occurs after a delay, retention increases dramatically with age. Specifically, in one study 18-day-old rats showed nearly complete forgetting after 7 days, whereas 100-day-old rats showed nearly perfect retention even after 42 days (Campbell & Campbell, 1962) . This rapid spontaneous forgetting displayed by the infant rat may provide a practical and useful way to examine the neural processes underlying spontaneous forgetting in general.
Therefore, the present study examines the neurobiological basis of spontaneous forgetting in the infant rat. Specifically, the role of GABA neurotransmission in the reactivation of forgotten memory in the infant rat is assessed. The GABAergic system is the dominant inhibitory system in the central nervous system of mammals, and it influences neuronal development, synaptic plasticity, learning, and memory (Haefely, 1990; Olsen, 2002) . GABA receptors are particularly abundant in the amygdala (McDonald, 1985) , a critical structure necessary for aversive learning (M. Davis, 1992; LeDoux, 2000) . Not surprisingly, GABAergic neurotransmission has been identified as the neural mechanism underlying inhibition of aversive memory, such as in the case of fear extinction (for review, see M. Davis & Myers, 2002) . Recently, we have demonstrated that GABA is also involved in the spontaneous forgetting in the infant rat (Kim, McNally, & Richardson, 2006; Kim & Richardson, 2007b ). In Kim et al. (2006) , 18-day-old rats received 3 pairings of a white-noise CS and a shock US. This training caused subsequent presentations of the CS to elicit fear, as measured by freezing 1 day after the training episode. Rapid forgetting was observed, as the amount of freezing observed significantly declined over a 10-day retention interval. Importantly, this forgetting was then alleviated by a pretest injection of FG7142, which is a GABA A receptor partial inverse agonist that reduces GABAergic inhibition. Follow-up experiments in that study showed that the attenuation of forgetting observed was not due to a nonspecific increase in freezing behavior. The FG7142 effect on the retrieval of a forgotten fear memory was subsequently replicated with 16-day-old rats that were tested 2 days after training (Kim & Richardson, 2007b) . These results indicate that spontaneously forgotten memories might be "inhibited" because of GABA activity and therefore cannot be retrieved under normal circumstances. Pretest injection of FG7142 removed this inhibition and permitted the retrieval of the memory.
On the basis of these findings, it may be the case that other manipulations that typically reduce forgetting may also work through reducing GABAergic inhibition. Among such manipulations is the reactivation effect, which refers to the recovery of a forgotten memory when a reminder is administered 24 hr prior to test (Spear & Parsons, 1976) . The reminder is an abbreviated form of the training episode and can vary depending on the training procedures employed in an experiment. For example, if an auditory CS and a shock US were used, the reminder might be a single, unsignaled shock (often reduced in intensity compared with during training). The improved performance of rats given this reminder is not a simple consequence of the shock reminder, because a group given only the reminder treatment without being initially trained does not exhibit behavior indicative of the target memory. The reactivation effect has been observed many times, whether aversive or nonaversive procedures were used, in rats as well as in human infants (J. Davis & Rovee-Collier, 1983; Hayne & Findley, 1995; Kim & Richardson, 2007a; Richardson & Campbell, 1991) . On the basis of our findings that GABAergic activity is involved in forgetting, the underlying mechanism of the reactivation effect may be the removal of GABAergic inhibition by the reminder treatment. This hypothesis was tested in the present study. Specifically, 16-day-old rats were given two pairings of an auditory CS and shock US. Rats trained this way at this age exhibit high levels of CS-elicited freezing at an immediate test but substantially reduced CS-elicited freezing (i.e., forgetting) at a test 48 hr later (Kim & Richardson, 2007b) . In the present study, we gave some rats a reminder shock US at 18 days of age and then injected either saline or midazolam. Midazolam is a benzodiazepine that increases GABAergic neurotransmission. If the reactivation effect is mediated by the reminder treatment's decreasing of the GABAergic inhibition, then rats given a post-reminder injection of midazolam should exhibit a diminished reactivation effect.
General Method

Subjects
Both experiments used experimentally naive Sprague-Dawley rats bred and housed in the School of Psychology, University of New South Wales. No more than one rat per litter was used per group. Rats were housed with their littermates and mother in plastic boxes (24.5 cm long ϫ 37 cm wide ϫ 27 cm high) covered by a wire lid. Rats were maintained on a 12-hr light-dark cycle (lights on at 6 a.m.) with food and water available ad libitum. All rats were treated according to the principles of animal use outlined 
Drug Injections
Injections of either midazolam (Roche Products Pty, Dee Why, New South Wales, Australia) or saline were given subcutaneously. Midazolam was dissolved in 0.9% w/v sterile saline. In both experiments, midazolam was injected at a dose of 2.5 mg/kg. All injections were given at a volume of 2 ml/kg, in a room adjacent to the test room.
Apparatus
Two types of experimental chambers were used in both experiments to provide different contexts. All chambers were housed within a separate wood cabinet so that external noise and visual stimulation were minimized. A low, constant background noise was produced by ventilation fans located within the wood cabinets. All conditioning sessions occurred in a single set of two identical chambers that were rectangular (13.5 cm long ϫ 9 cm wide ϫ 9 cm high), with the front wall, rear wall, and ceiling constructed of clear Plexiglas. The floor and side walls consisted of 3-mm-thick stainless steel rods set 1 cm apart. Two high-frequency speakers were located 8 cm from either side of the chamber. A red lightemitting diode (LED) located on the cabinet door provided the only illumination during conditioning sessions. All reactivation and testing sessions occurred in the second type of chamber, which was rectangular (30 cm long ϫ 30 cm wide ϫ 23 cm high) and wholly constructed of Plexiglas, with the exception of the grid floor, which consisted of 3-mm-thick stainless steel rods set 1 cm apart. All the walls were transparent, except for the two side walls, which consisted of vertical black and white stripes (each 5 cm wide). Two high-frequency speakers were mounted on the ceiling. White and red LEDs located on the cabinet provided illumination during reactivation-test sessions.
The CS was a white noise; the noise level in the chambers was increased by 8 dB when the CS was presented. The US was a footshock. A custom-built constant-current shock generator could deliver shocks to the floor of all chambers as required. A computer controlled all presentations of the CS and the US. The software and hardware used were developed at the University of New South Wales.
Procedure
Conditioning. Sixteen-day-old rats were placed in the experimental chambers, and after a 2-min adaptation period, the CS was presented for 10 s. Shock (0.6 mA, 1 s) was administered during the last second of the CS. Two pairings of the CS and shock were given. The intertrial interval was 110 s.
Reactivation. Rats were placed in the experimental chambers, and after a 2-min adaptation period, a single shock US (0.4 mA, 1 s) was administered. In a previous study, it was shown that this reminder treatment leads to effective reactivation of forgotten memory without inducing freezing in nontrained rats (Kim & Richardson, 2007a) .
Test. Rats were placed in the experimental chambers for a baseline period of 1 min, and then the CS was presented for 2 min. Freezing was scored by a time sampling procedure whereby each rat was scored every 3 s as freezing or not freezing. For each rat, the percentage of observations that were scored as freezing was computed for both the baseline and the CS period. A second scorer unaware of the experimental condition of each rat scored a random sample of approximately 50% of all rats tested; the interrater reliability was high (r ϭ .96).
Experiment 1
This experiment was designed to assess whether GABAergic neurotransmission is involved in the memory reactivation effect. The hypothesis was assessed by giving rats systemic injections of either midazolam or saline immediately after the reminder treatment.
Method
Three groups of rats received two pairings of the white noise CS and the shock US at 16 (Ϯ1) days of age. Two days later, groups reminder-midazolam and reminder-saline received the reminder treatment and immediately after received injections of either midazolam or saline. Group no reminder-saline did not receive the reminder treatment but was merely exposed to the experimental chamber and then immediately after received an injection of saline. All groups were tested for CS-elicited fear 1 day later.
Results and Discussion
One rat from group reminder-saline was excluded from the statistical analysis because it was an outlier at test (3 SDs away from the group mean). The mean and standard error of the mean (SEM) levels of freezing at baseline and at test are shown in Figure 1 .
An analysis of variance revealed that the mean levels of baseline freezing did not differ across groups, F(2, 19) ϭ 2.69, p ϭ .09. In contrast, CS-elicited freezing differed significantly between groups, F(2, 19) ϭ 16.95, p Ͻ .0001, and subsequent Tukey pairwise comparisons showed that group reminder-saline exhibited more freezing to the CS than did group no reminder-saline ( p Ͻ .0001). This result, which shows that the reminder treatment successfully alleviated forgetting, replicates previous findings that used parameters identical to those in this experiment (Kim & Richardson, 2007a) . Furthermore, group reminder-midazolam exhibited significantly less freezing than did group reminder-saline ( p Ͻ .0001) and did not differ from group no reminder-saline ( p ϭ .88). Taken together, these results show that a post-reminder injection of midazolam attenuated the reactivation effect. This finding is consistent with the hypothesis that reminder treatments that lead to the recovery of a forgotten memory in infant rats work via alterations in GABA activity.
Experiment 2
The results of Experiment 1 suggest that the processes underlying the reactivation effect involve a decrease in GABAergic inhibitory activity because midazolam, which increases GABAergic activity, blocked the reactivation effect. An alternative explanation would be that midazolam in and of itself may have effects regardless of the reminder treatment. For example, midazolam has anxiolytic effects and can impair freezing (Harris & Westbrook, 1994) . Although it is unlikely that midazolam impaired freezing at test in Experiment 1, because the injection occurred 24 hr before test, it may be the case that midazolam has nonspecific effects unrelated to forgetting or retrieval. Therefore, in Experiment 2 midazolam was injected either immediately or 2 hr after the reminder episode. If the main finding of Experiment 1 is due to midazolam having nonspecific and lasting physiological effects, then the interval between the reminder episode and midazolam injection should not be important. However, if midazolam attenuates the reactivation effect by countering the decrease in GABAergic inhibition after the reminder treatment, then the administration of midazolam 2 hr after the reminder episode should not impair the effectiveness of the reminder treatment.
Method
Two groups of rats 16 (Ϯ1) days old were fear-conditioned as in Experiment 1. Two days later, both groups received a reminder treatment and then were injected with midazolam, either immediately or 2 hr after the reminder episode. The next day, both groups were tested for CS-elicited freezing.
Results and Discussion
The mean level of baseline freezing did not differ between groups, t(16) ϭ 0.27, p ϭ .79. During the CS presentation, however, rats that received the midazolam injection 2 hr after the reminder episode displayed significantly more freezing than did the rats that received the injection immediately after the reminder treatment, t(16) ϭ 2.43, p ϭ .027 (see Figure 2 ). This finding shows that injecting midazolam 2 hr after the reminder episode does not impair reactivation of a forgotten memory. Indeed, these rats exhibited levels of CS-elicited freezing that were very similar Figure 1 . The mean (Ϯ SEM) levels of freezing at test in Experiment 1. Group reminder saline (n ϭ 7) displayed significantly higher freezing than did groups no reminder saline (n ϭ 8) and reminder midazolam (n ϭ 7). * indicates a significant difference from the other groups.
to that observed in group reminder-saline in Experiment 1 (68% vs. 59%, respectively). It appears that the effect of midazolam is specific to the reminder episode because delaying its injection until 2 hr after the reminder treatment did not reduce the reactivation effect.
General Discussion
The present findings are interesting because they elucidate one potential neural mechanism underlying the reactivation effect. It appears that a reminder treatment reactivates a forgotten memory in infant rats by reducing GABAergic neurotransmission because increasing GABA by injecting midazolam immediately after the reminder treatment blocked the reactivation effect (Experiment 1). This effect of midazolam was specific to the reminder treatment, as midazolam did not reduce the reactivation effect when injected 2 hr after the reminder episode (Experiment 2). We would expect that other agents that increase GABAergic activity would have the same effect. Overall, these results are consistent with our previous reports that identified GABAergic involvement in the rapid spontaneous forgetting observed in the infant rat (Kim et al., 2006; Kim & Richardson, 2007b) .
Finding that a reminder treatment reactivates a forgotten memory by modulating GABAergic activity indicates that the forgetting that occurs in infant rats is a retrieval deficit that is due to the endogenous activation of the GABAergic system early in development. Indeed, GABA activity is particularly pronounced early in development (Frahm & Draguhn, 2001) . For example, the expression of GABA A receptor mRNA in the rat forebrain is low at birth but shows a dramatic increase reaching a maximum during the early postnatal period until it starts to gradually decline to adult levels 2-3 weeks after birth (Zhang, Sato, Araki, & Tohyama, 1992) . Some studies suggest that this may also be the case in humans (e.g., Snead, 1994) . The present results, taken together with these findings, suggest that maturation of the GABAergic system (i.e., initially hyperactive and then adultlike) is one of the important factors involved in a rat's increasing retention capacity over development. Another neurotransmitter system that has recently been identified as being important in memory development is the opioid system (Weber, McNally, & Richardson, 2006) . Given this finding, it would be informative to determine whether manipulations of the opiate system also affect the memory reactivation effect.
Interestingly, it is unclear whether the rapid forgetting observed in immature rats reflects a qualitatively unique type of memory failure or a quantitative exaggeration of general forgetting observed in mature rats. Infantile amnesia and spontaneous forgetting in adult rats do share several similarities. Forgetting at both ages is influenced by contextual cues (e.g., Richardson, Riccio, & Axiotis, 1986; Solheim, Hensler, & Spear, 1980; Spear, 1978) . Additionally, various reminder treatments are effective in alleviating spontaneous or induced forgetting not only in immature rats but also in mature rats (e.g., Deweer & Sara, 1984; Riccio & Richardson, 1984; Spear & Parsons, 1976) . The present results showing GABAergic involvement in infantile amnesia supports the idea that the forgetting observed early in development is an exaggerated form of spontaneous forgetting rather than a qualitatively different type of forgetting, because GABA activity is also involved in memory in the adult rat. Increasing GABAergic activity has been found to disrupt memory retrieval in adult rats, even when potential state-dependent effects have been accounted for (e.g., Cahill, Brioni, & Izquierdo, 1986; Venault et al. 1986 ). Although no one has examined whether decreasing GABA activity in the adult rat leads to recovery of a spontaneously forgotten memory, it has been shown that decreasing GABA activity by FG7142 leads to the recovery of a previously extinguished memory in adult rats (Harris & Westbrook, 1998) . Therefore, GABAergic neurotransmission may be involved in spontaneous forgetting across all ages, and infantile amnesia is simply a consequence of the higher endogenous GABA activation in the developing rat. Given the present findings, it would be interesting to see whether reminder treatments that recover spontaneously forgotten memory in adult rats are also mediated by modulations in GABAergic activity. Finding that GABA is involved in spontaneous forgetting in adult rats would further support the idea that infantile amnesia is an exaggerated form of forgetting that occurs in adults.
Alternatively, the rapid forgetting seen in immature rats may be a special type of memory loss. Although not much is known about the differences between spontaneous forgetting in immature and mature rats, we have recently shown substantial developmental differences in extinction. For example, extinction is contextdependent in 23-day-old rats but context-independent in 16-dayold rats (Kim & Richardson, 2007b; Yap & Richardson, 2007) . In addition, an extinguished fear response can be reinstated by a reminder treatment in 23-day-old rats but not in 16-day-old rats (Kim & Richardson, 2007a) . Finally, pretest injections of the GABA inverse agonist FG7142 attenuate extinction in rats that are 23 days old but not in those that are 16 days old (Kim & Richardson, 2007b ). This consistent pattern of differences suggests that fundamentally different processes mediate extinction at these two ages. Therefore, it could be the case that spontaneous forgetting is also mediated by very different neural mechanisms across development. Future research is needed to address this issue. The group that received injection of midazolam 2 hr after the reminder treatment froze significantly more than did the group that received midazolam immediately after the reminder treatment (ns ϭ 9). * indicates a significant difference from the other group.
